The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Recombinant Therapeutic Protein Revenue 1.5 Market Analysis by Type 1.5.1 Global Recombinant Therapeutic Protein Market Size Growth Rate by Type: 2020 VS 2026 1.5.2 Recombinant Human Collage 1.5.3 Recombinant Human Serum Albumin 1.6 Market by Application 1.6.1 Global Recombinant Therapeutic Protein Market Share by Application: 2021-2026 1.6.2 Medicine 1.6.3 Scientific Research 1.6.4 Others 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Recombinant Therapeutic Protein Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter's Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Recombinant Therapeutic Protein Market Players Profiles 3.1 Boehringer Ingelheim 3.1.1 Boehringer Ingelheim Company Profile 3.1.2 Boehringer Ingelheim Recombinant Therapeutic Protein Product Specification 3.1.3 Boehringer Ingelheim Recombinant Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.2 Regeneron Pharmaceuticals 3.2.1 Regeneron Pharmaceuticals Company Profile 3.2.2 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Product Specification 3.2.3 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.3 Eli Liily 3.3.1 Eli Liily Company Profile 3.3.2 Eli Liily Recombinant Therapeutic Protein Product Specification 3.3.3 Eli Liily Recombinant Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.4 Bristol-Myers Squibb 3.4.1 Bristol-Myers Squibb Company Profile 3.4.2 Bristol-Myers Squibb Recombinant Therapeutic Protein Product Specification 3.4.3 Bristol-Myers Squibb Recombinant Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.5 Novartis 3.5.1 Novartis Company Profile 3.5.2 Novartis Recombinant Therapeutic Protein Product Specification 3.5.3 Novartis Recombinant Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.6 Celldex Therapeutics 3.6.1 Celldex Therapeutics Company Profile 3.6.2 Celldex Therapeutics Recombinant Therapeutic Protein Product Specification 3.6.3 Celldex Therapeutics Recombinant Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.7 Takeda 3.7.1 Takeda Company Profile 3.7.2 Takeda Recombinant Therapeutic Protein Product Specification 3.7.3 Takeda Recombinant Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.8 Merck 3.8.1 Merck Company Profile 3.8.2 Merck Recombinant Therapeutic Protein Product Specification 3.8.3 Merck Recombinant Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.9 GlaxoSmithKline 3.9.1 GlaxoSmithKline Company Profile 3.9.2 GlaxoSmithKline Recombinant Therapeutic Protein Product Specification 3.9.3 GlaxoSmithKline Recombinant Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.10 Roche 3.10.1 Roche Company Profile 3.10.2 Roche Recombinant Therapeutic Protein Product Specification 3.10.3 Roche Recombinant Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2015-2020) 4 Global Recombinant Therapeutic Protein Market Competition by Market Players 4.1 Global Recombinant Therapeutic Protein Production Capacity Market Share by Market Players (2015-2020) 4.2 Global Recombinant Therapeutic Protein Revenue Market Share by Market Players (2015-2020) 4.3 Global Recombinant Therapeutic Protein Average Price by Market Players (2015-2020) 5 Global Recombinant Therapeutic Protein Production by Regions (2015-2020) 5.1 North America 5.1.1 North America Recombinant Therapeutic Protein Market Size (2015-2020) 5.1.2 Recombinant Therapeutic Protein Key Players in North America (2015-2020) 5.1.3 North America Recombinant Therapeutic Protein Market Size by Type (2015-2020) 5.1.4 North America Recombinant Therapeutic Protein Market Size by Application (2015-2020) 5.2 East Asia 5.2.1 East Asia Recombinant Therapeutic Protein Market Size (2015-2020) 5.2.2 Recombinant Therapeutic Protein Key Players in East Asia (2015-2020) 5.2.3 East Asia Recombinant Therapeutic Protein Market Size by Type (2015-2020) 5.2.4 East Asia Recombinant Therapeutic Protein Market Size by Application (2015-2020) 5.3 Europe 5.3.1 Europe Recombinant Therapeutic Protein Market Size (2015-2020) 5.3.2 Recombinant Therapeutic Protein Key Players in Europe (2015-2020) 5.3.3 Europe Recombinant Therapeutic Protein Market Size by Type (2015-2020) 5.3.4 Europe Recombinant Therapeutic Protein Market Size by Application (2015-2020) 5.4 South Asia 5.4.1 South Asia Recombinant Therapeutic Protein Market Size (2015-2020) 5.4.2 Recombinant Therapeutic Protein Key Players in South Asia (2015-2020) 5.4.3 South Asia Recombinant Therapeutic Protein Market Size by Type (2015-2020) 5.4.4 South Asia Recombinant Therapeutic Protein Market Size by Application (2015-2020) 5.5 Southeast Asia 5.5.1 Southeast Asia Recombinant Therapeutic Protein Market Size (2015-2020) 5.5.2 Recombinant Therapeutic Protein Key Players in Southeast Asia (2015-2020) 5.5.3 Southeast Asia Recombinant Therapeutic Protein Market Size by Type (2015-2020) 5.5.4 Southeast Asia Recombinant Therapeutic Protein Market Size by Application (2015-2020) 5.6 Middle East 5.6.1 Middle East Recombinant Therapeutic Protein Market Size (2015-2020) 5.6.2 Recombinant Therapeutic Protein Key Players in Middle East (2015-2020) 5.6.3 Middle East Recombinant Therapeutic Protein Market Size by Type (2015-2020) 5.6.4 Middle East Recombinant Therapeutic Protein Market Size by Application (2015-2020) 5.7 Africa 5.7.1 Africa Recombinant Therapeutic Protein Market Size (2015-2020) 5.7.2 Recombinant Therapeutic Protein Key Players in Africa (2015-2020) 5.7.3 Africa Recombinant Therapeutic Protein Market Size by Type (2015-2020) 5.7.4 Africa Recombinant Therapeutic Protein Market Size by Application (2015-2020) 5.8 Oceania 5.8.1 Oceania Recombinant Therapeutic Protein Market Size (2015-2020) 5.8.2 Recombinant Therapeutic Protein Key Players in Oceania (2015-2020) 5.8.3 Oceania Recombinant Therapeutic Protein Market Size by Type (2015-2020) 5.8.4 Oceania Recombinant Therapeutic Protein Market Size by Application (2015-2020) 5.9 South America 5.9.1 South America Recombinant Therapeutic Protein Market Size (2015-2020) 5.9.2 Recombinant Therapeutic Protein Key Players in South America (2015-2020) 5.9.3 South America Recombinant Therapeutic Protein Market Size by Type (2015-2020) 5.9.4 South America Recombinant Therapeutic Protein Market Size by Application (2015-2020) 5.10 Rest of the World 5.10.1 Rest of the World Recombinant Therapeutic Protein Market Size (2015-2020) 5.10.2 Recombinant Therapeutic Protein Key Players in Rest of the World (2015-2020) 5.10.3 Rest of the World Recombinant Therapeutic Protein Market Size by Type (2015-2020) 5.10.4 Rest of the World Recombinant Therapeutic Protein Market Size by Application (2015-2020) 6 Global Recombinant Therapeutic Protein Consumption by Region (2015-2020) 6.1 North America 6.1.1 North America Recombinant Therapeutic Protein Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Recombinant Therapeutic Protein Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Recombinant Therapeutic Protein Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Recombinant Therapeutic Protein Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Recombinant Therapeutic Protein Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Recombinant Therapeutic Protein Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Recombinant Therapeutic Protein Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Recombinant Therapeutic Protein Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Recombinant Therapeutic Protein Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Recombinant Therapeutic Protein Consumption by Countries 7 Global Recombinant Therapeutic Protein Production Forecast by Regions (2021-2026) 7.1 Global Forecasted Production of Recombinant Therapeutic Protein (2021-2026) 7.2 Global Forecasted Revenue of Recombinant Therapeutic Protein (2021-2026) 7.3 Global Forecasted Price of Recombinant Therapeutic Protein (2021-2026) 7.4 Global Forecasted Production of Recombinant Therapeutic Protein by Region (2021-2026) 7.4.1 North America Recombinant Therapeutic Protein Production, Revenue Forecast (2021-2026) 7.4.2 East Asia Recombinant Therapeutic Protein Production, Revenue Forecast (2021-2026) 7.4.3 Europe Recombinant Therapeutic Protein Production, Revenue Forecast (2021-2026) 7.4.4 South Asia Recombinant Therapeutic Protein Production, Revenue Forecast (2021-2026) 7.4.5 Southeast Asia Recombinant Therapeutic Protein Production, Revenue Forecast (2021-2026) 7.4.6 Middle East Recombinant Therapeutic Protein Production, Revenue Forecast (2021-2026) 7.4.7 Africa Recombinant Therapeutic Protein Production, Revenue Forecast (2021-2026) 7.4.8 Oceania Recombinant Therapeutic Protein Production, Revenue Forecast (2021-2026) 7.4.9 South America Recombinant Therapeutic Protein Production, Revenue Forecast (2021-2026) 7.4.10 Rest of the World Recombinant Therapeutic Protein Production, Revenue Forecast (2021-2026) 7.5 Forecast by Type and by Application (2021-2026) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026) 7.5.2 Global Forecasted Consumption of Recombinant Therapeutic Protein by Application (2021-2026) 8 Global Recombinant Therapeutic Protein Consumption Forecast by Regions (2021-2026) 8.1 North America Forecasted Consumption of Recombinant Therapeutic Protein by Country 8.2 East Asia Market Forecasted Consumption of Recombinant Therapeutic Protein by Country 8.3 Europe Market Forecasted Consumption of Recombinant Therapeutic Protein by Countriy 8.4 South Asia Forecasted Consumption of Recombinant Therapeutic Protein by Country 8.5 Southeast Asia Forecasted Consumption of Recombinant Therapeutic Protein by Country 8.6 Middle East Forecasted Consumption of Recombinant Therapeutic Protein by Country 8.7 Africa Forecasted Consumption of Recombinant Therapeutic Protein by Country 8.8 Oceania Forecasted Consumption of Recombinant Therapeutic Protein by Country 8.9 South America Forecasted Consumption of Recombinant Therapeutic Protein by Country 8.10 Rest of the world Forecasted Consumption of Recombinant Therapeutic Protein by Country 9 Global Recombinant Therapeutic Protein Sales by Type (2015-2026) 9.1 Global Recombinant Therapeutic Protein Historic Market Size by Type (2015-2020) 9.2 Global Recombinant Therapeutic Protein Forecasted Market Size by Type (2021-2026) 10 Global Recombinant Therapeutic Protein Consumption by Application (2015-2026) 10.1 Global Recombinant Therapeutic Protein Historic Market Size by Application (2015-2020) 10.2 Global Recombinant Therapeutic Protein Forecasted Market Size by Application (2021-2026) 11 Global Recombinant Therapeutic Protein Manufacturing Cost Analysis 11.1 Recombinant Therapeutic Protein Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Recombinant Therapeutic Protein 12 Global Recombinant Therapeutic Protein Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Recombinant Therapeutic Protein Distributors List 12.3 Recombinant Therapeutic Protein Customers 12.4 Recombinant Therapeutic Protein Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Price : US$ 3,500 | Date : May 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 108 |
Price : US$ 2,450 | Date : Jan 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 244 |
Price : US$ 3,500 | Date : May 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 146 |
Price : US$ 3,500 | Date : May 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 115 |
Price : US$ 3,500 | Date : Apr 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 123 |
We will be happy to help you find what you need. Please call us or write to us: